603718 logo

Shanghai Hile Bio-Technology Co., Ltd. Stock Price

SHSE:603718 Community·CN¥4.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603718 Share Price Performance

CN¥0
-8.54 (-100.00%)
CN¥0
-8.54 (-100.00%)
Price CN¥0

603718 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record.

1 Risk
2 Rewards

Shanghai Hile Bio-Technology Co., Ltd. Key Details

CN¥246.4m

Revenue

CN¥60.3m

Cost of Revenue

CN¥186.0m

Gross Profit

CN¥14.7m

Other Expenses

CN¥171.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.26
75.51%
69.55%
0.2%
View Full Analysis

About 603718

Founded
1981
Employees
366
CEO
Benyi Han
WebsiteView website
www.hile-bio.com

Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; and inactivated vaccine for streptococcus suis. It also provides inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease, and avian infectious bronchitis combined live vaccines. The company was founded in 1981 and is based in Shanghai, China.

Recent 603718 News & Updates

Recent updates

No updates